A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Compare the Efficacy and Safety of Three Doses of Botulinum Toxin Type A (Dysport) With Placebo in Upper Limb Spasticity After Stroke
A. M. O. Bakheit(Southampton General Hospital), Christian Neumann(San Francisco Center for Psychoanalysis), Christine Collin(University of Nottingham), Christopher D. Ward(University of Nottingham), Jörg Wissel(University of Potsdam), Anthony B. Ward(University of Nottingham), R. Benecke(Children's Hospital of Philadelphia), Werner Poewe(Innsbruck Medical University), Jörg Müller(Krankenhaus Bruneck), A. F. Thilmann(University of Nottingham), F. Müller(University of Nottingham)
Cited by 298
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846